Literature DB >> 34146057

Magnetic resonance imaging in rhino-orbital-cerebral mucormycosis.

Kanduri Sreshta1, Tarjani Vivek Dave2, Dandu Ravi Varma1, Akshay Gopinathan Nair3, Nandini Bothra2, Milind N Naik2, Srinivas Kishore Sistla4.   

Abstract

Coronavirus disease-associated mucormycosis (CAM) is an established clinical entity in India. In the past 4 months, there has been a sharp upsurge in the number of CAM cases in most parts of the country. Early diagnosis can be lifesaving. Magnetic resonance imaging (MRI) imaging remains the corner stone of management in patients with ROCM. This review discussed the utility of MRI imaging in ROCM with an emphasis on the ideal MRI protocol in a suspected case of ROCM, the pathways of spread of infection, the classic diagnostic features, MRI for staging of the disease, MRI for prognostication, MRI for follow up, and imaging features of common differentials in ROCM. The pit falls of MRI imaging and a comparison of CT and MRI imaging in ROCM are discussed. The clinical interpretation of areas of contrast uptake and those of necrosis and its relevance to treatment are discussed. This review aims to familiarize every member of the multidisciplinary team involved in managing these patients to be able to interpret the findings on MRI in ROCM.

Entities:  

Keywords:  COVID-19; magnetic resonance imaging (MRI); mucormycosis

Year:  2021        PMID: 34146057     DOI: 10.4103/ijo.IJO_1439_21

Source DB:  PubMed          Journal:  Indian J Ophthalmol        ISSN: 0301-4738            Impact factor:   1.848


  7 in total

1.  Image challenge: A diabetic man with facial swelling following recent Covid-19 infection.

Authors:  Melissa Chowdhury; Junko Takata; Issa Beegun; Chris Burd; Taranjit Tatla; Tumena Corrah
Journal:  Clin Infect Pract       Date:  2021-12-08

2.  Isolated Cerebral Mucormycosis Caused by Lichtheimia Species in a Polytrauma Patient.

Authors:  Vasiliki Mamali; Christos Koutserimpas; Olympia Zarkotou; Georgia Vrioni; George Samonis
Journal:  Diagnostics (Basel)       Date:  2022-01-31

Review 3.  Mucormycosis in COVID-19 patients: predisposing factors, prevention and management.

Authors:  Pavan Kumar Rudrabhatla; Aravind Reghukumar; Sanjeev V Thomas
Journal:  Acta Neurol Belg       Date:  2021-11-24       Impact factor: 2.471

4.  Orbital magnetic resonance imaging profile and clinicoradiological correlation in COVID-19-associated rhino-orbital-cerebral mucormycosis: A single-center study of 270 patients from North India.

Authors:  Maya Hada; Parul Gupta; Meenu Bagarhatta; Koushik Tripathy; Anita Harsh; Kamlesh Khilnani; Kuldeep Mendiratta; Sunita Agarwal; Jugal Kishore Chouhan; Sudhir Bhandari
Journal:  Indian J Ophthalmol       Date:  2022-02       Impact factor: 2.969

5.  Commentary: Data and COVID-19-associated mucormycosis: Time to pause and reassess?

Authors:  Akshay Gopinathan Nair
Journal:  Indian J Ophthalmol       Date:  2022-03       Impact factor: 2.969

6.  Post-COVID mucormycosis osteomyelitis and its imaging manifestations in the North of Iran: case series.

Authors:  Safa Motevasseli; Ali Nazarpour; Zahra Dalili Kajan; Zahra Yousefi; Negar Khosravifard; Faezeh Kashi; Niousha Roudbari
Journal:  Oral Radiol       Date:  2022-09-05       Impact factor: 1.882

7.  Management of Mucormycosis in Post COVID-19 Patients and Its Outcome in a Tertiary Care Center: Our Experience.

Authors:  Kulkarni Manik Rao; N Pooja
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2022-10-15
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.